Covid19 vaccine – US to share AstraZeneca vaccine with the world post safety checks
The US will begin sharing its entire stock of AstraZeneca Covid-19 vaccines with the world once it clears federal safety reviews, the White House said Monday, with as many as 60 million doses expected to be available for export in the coming months.
The move greatly expands on the Biden administration’s action last month to share about 4 million doses of the vaccine with Mexico and Canada. The AstraZeneca vaccine is widely in use around the world but has not yet been authorized by the US Food and Drug Administration.
India’s hospitals have been overwhelmed, with beds and oxygen in short supply and crematoriums running out of space as the country recorded a million new cases in just three days. Reports and images of people dying on the pavement waiting for treatment have underscored the severity of the surge.
More than 3 million people worldwide have died of Covid-19, including more than 572,000 in the US. The US has vaccinated more than 53% of its adult population with at least one dose of its three authorized vaccines from Pfizer, Moderna and J&J, and it expects to have enough supply for its entire population by early summer.